RN7SL213P

Across TCGA pan-cancer cohorts, RN7SL213P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RN7SL213P data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RN7SL213P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL213P expression acts as an unfavorable survival marker, although some lineages such as KICH and LUAD show a favorable association.

KICH, LUAD, and ACC are the cancer types where RN7SL213P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Median	II,III,IV	1.000	0.660	.002	55	view →
LUAD	OS	Median	II,III,IV	0.594	0.347	.006	55	view →
ACC	OS	Tertile	IV	0.247	0.777	<.001	36	view →
BRCA	OS	Tertile	IV	0.954	0.471	.009	34	view →
CHOL	DFS	Median	All	0.610	0.209	.018	30	view →
PRAD	DFS	Tertile	All	0.889	0.955	.004	22	view →
COAD	DFS	Tertile	III,IV	0.543	0.694	.028	18	view →
ESCA	OS	Quartile	III,IV	0.616	0.267	.011	18	view →
UVM	DFS	Quartile	III,IV	0.262	0.682	.001	15	view →
SKCM	OS	Quartile	All	0.184	0.434	<.001	13	view →
READ	DFS	Tertile	All	0.653	0.874	.016	12	view →
UCS	DFS	Tertile	IV	0.981	0.651	.042	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RN7SL213P–KICH (OS)

Open the KICH breakdown →